Search Results - "Colacci, Michael"

Demographics, medication use, and admission characteristics of patients hospitalized with diabetes in Ontario, Canada: A retrospective cohort study.

Authors: Colacci, Michael Raissi, Afsaneh Biering-Sørensen, Tor et al.

Source: PLoS ONE. 8/29/2024, Vol. 19 Issue 8, p1-13. 13p.

Effect of disability, homelessness, and neighborhood marginalization on risk adjustment for hospital performance measurement.

Authors: Roberts, Surain B Colacci, Michael Shi, Jiamin et al.

Source: American Journal of Epidemiology. Nov2025, Vol. 194 Issue 11, p3079-3090. 12p.

An Update to the Kaiser Permanente Inpatient Risk Adjustment Methodology Accurately Predicts In-Hospital Mortality: a Retrospective Cohort Study.

Authors: Roberts, Surain B. Colacci, Michael Razak, Fahad et al.

Source: JGIM: Journal of General Internal Medicine. Nov2023, Vol. 38 Issue 15, p3303-3312. 10p.

Association Between SGLT2 Inhibitor Use and Change in Hemoglobin Among Adults with Diabetes: A Nationwide Cohort Study.

Authors: Lassen, Mats C. Højbjerg Colacci, Michael Pareek, Manan et al.

Source: JGIM: Journal of General Internal Medicine. Aug2024, Vol. 39 Issue 10, p1945-1947. 3p.

C-terminal region of teneurin-1 co-localizes with the dystroglycan complex in adult mouse testes and regulates testicular size and testosterone production.

Authors: Chand, Dhan Colacci, Michael Dixon, Katelyn et al.

Source: Histochemistry & Cell Biology. Feb2014, Vol. 141 Issue 2, p191-211. 21p. 8 Color Photographs, 1 Black and White Photograph, 1 Chart, 4 Graphs.

Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes.

Authors: Colacci, Michael Raudanskis, Ashley Fralick, Michael

Source: Journal of Diabetes & its Complications. Oct2025, Vol. 39 Issue 10, pN.PAG-N.PAG. 1p.

Non-ABO red cell antibodies and risk of COVID-19.

Authors: Ray, Joel G. Colacci, Michael Schull, Michael J. et al.

Source: International Journal of Infectious Diseases. Jul2021, Vol. 108, p179-182. 4p.

Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of heart failure: A nationwide cohort study of older adults with diabetes mellitus.

Authors: Fralick, Michael Colacci, Michael Thiruchelvam, Deva et al.

Source: Diabetes, Obesity & Metabolism. Apr2021, Vol. 23 Issue 4, p950-960. 11p.

Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice: A Cohort Study.

Authors: Fralick, Michael Colacci, Michael Schneeweiss, Sebastian et al.

Source: Annals of Internal Medicine. 4/7/2020, Vol. 172 Issue 7, p463-473. 11p. 3 Diagrams, 8 Charts, 2 Graphs.

Oral Anticoagulant Utilization in the United States and United Kingdom.

Authors: Colacci, Michael Tseng, Eric K. Sacks, Chana A. et al.

Source: JGIM: Journal of General Internal Medicine. Aug2020, Vol. 35 Issue 8, p2505-2507. 3p. 1 Graph.

Growth and Development in Extremely Low Birth Weight Infants After the Introduction of Exclusive Human Milk Feedings.

Authors: Colacci, Michael Murthy, Karna DeRegnier, Raye-Ann O. et al.

Source: American Journal of Perinatology. 2017, Vol. 34 Issue 2, p130-137. 8p.

ASSOCIATION BETWEEN SGLT2 INHIBITOR USE AND CHANGE IN HEMOGLOBIN AMONG ADULTS WITH DIABETES.

Authors: Lassen, Mats Colacci, Michael Pareek, Manan et al.

Source: Journal of the American College of Cardiology (JACC). 2024 Supplement, Vol. 83 Issue 13, p1903-1903. 1p.

This result is not displayed to guests.
Login for full access.

Clinical evaluation of a machine learning–based early warning system for patient deterioration.

Authors: Verma, Amol A. Stukel, Therese A. Colacci, Michael et al.

Source: Canadian Medical Association Journal (CMAJ). 9/16/2024, Vol. 196 Issue 30, pE1027-E1037. 11p.

Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis.

Authors: Fralick, Michael Colacci, Michael Odutayo, Ayodele et al.

Source: Journal of Diabetes & its Complications. Nov2020, Vol. 34 Issue 11, pN.PAG-N.PAG. 1p.

Modern-day scurvy.

Authors: Colacci, Michael Gold, Wayne L. Shah, Rupal

Source: Canadian Medical Association Journal (CMAJ). 1/27/2020, Vol. 192 Issue 4, pE96-E96. 1p. 1 Color Photograph.

Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study.

Authors: Fralick, Michael Højbjerg Lassen, Mats C. Rangrej, Jagadish et al.

Source: Journal of Diabetes & its Complications. Oct2025, Vol. 39 Issue 10, pN.PAG-N.PAG. 1p.

Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist use in hospital among adults with diabetes.

Authors: Raudanskis, Ashley Sarma, Shohinee Biering-Sørensen, Tor et al.

Source: Journal of Diabetes & its Complications. Feb2025, Vol. 39 Issue 2, pN.PAG-N.PAG. 1p.

Association of sodium glucose co-transporter-2 inhibitors with risk of diabetic ketoacidosis among hospitalized patients: A multicentre cohort study.

Authors: Sarma, Shohinee Hodzic-Santor, Benazir Raissi, Afsaneh et al.

Source: Journal of Diabetes & its Complications. Sep2024, Vol. 38 Issue 9, pN.PAG-N.PAG. 1p.

Development and external validation of tools for categorizing diagnosis codes in international hospital data.

Authors: Malecki, Sarah L. Loffler, Anne Tamming, Daniel et al.

Source: International Journal of Medical Informatics. Sep2024, Vol. 189, pN.PAG-N.PAG. 1p.